How would you treat a young patient with classical intermediate-risk Hodgkin lymphoma who has an underlying DNA repair-deficiency disorder, such as congenital mismatch repair disorder or ataxia telangiectasia?
How does your treatment approach vary depending on the underlying predisposition?
Community PollStarted
How would you treat a young patient with classical intermediate-risk Hodgkin lymphoma who has an underlying DNA repair-deficiency disorder, such as congenital mismatch repair disorder or ataxia telangiectasia?
2 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet Member
Pediatric Hematology/Oncology · Georgetown University Hospital
Answered on
It depends on the DNA repair disorder.
Join for free or sign in to see the full answer